Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-06-001806
Filing Date
2006-07-18
Accepted
2006-07-18 17:07:58
Documents
1
Period of Report
2006-07-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3160
  Complete submission text file 0001127602-06-001806.txt   4999
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 111 W. 57TH STREET SUITE 1100 NEW YORK NY 10019
Business Address
BROWNE G MORGAN (Reporting) CIK: 0001111363 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 06967645